Results 201 to 203 of about 68,927 (203)

Spironolactone in patients on chronic haemodialysis at high risk of adverse cardiovascular outcomes (ALCHEMIST): a multicentre, double-blind, randomised, placebo-controlled trial and updated meta-analysis

Lancet, The
exaly  

Haemodialysis

1980
openaire   +1 more source

Haemodialysis.

Xianggang hu li za zhi. The Hong Kong nursing journal, 1973
openaire   +1 more source